Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 820 results for "merck co"

Merck Announces U.S. Food And Drug Administration Acceptance Of New Drug Application For Grazoprevir/Elbasvir, An Investigational Therapy For Treatment Of Chronic Hepatitis C Genotypes 1, 4 And 6 Infection

Merck & Co. (MRK) Snaps up Israel Oncology Firm cCam Biotherap...

Merck Enhances Immuno-Oncology Portfolio with Acquisition of cCAM Biotherapeutics KENILWORTH, N.J. & MISGAV, Israel, Jul 28, 2015 (BUSINESS WIRE) -- Merck ... ClinicSpace, 16 hours ago

Trade-Ideas: Merck (MRK) Is Today's "Storm The Castle" Stock

Reddit Email Reprint Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer. Trade-Ideas LLC identified Merck ( MRK ...
 TheStreet.com11 hours ago Dow Jones (DJIA) Today: Merck (MRK) Higher  TheStreet.com1 day ago Merck (MRK) Is Today's Unusual Social Activity Stock  TheStreet.com1 day ago
Pharma Letter

Merck ups FY earnings view; Q2 beats estimates

Pharma giant Merck & Co on Tuesday raised its outlook for full-year profit while posting a second-quarter… In order to access this content you need to be logged into the site and have an active subscription or trial subscription. Please login , ...
 Pharma Letter17 hours ago Merck Profit Beats Second-Quarter Estimates, Target Raised  Bloomberg1 day ago Merck & Co.'s second-quarter sales, profit drop  FirstWord Pharma1 day ago

Company News for July 29, 2015 - Corporate Summary

• Merck & Co. Inc.'s ( MRK ) shares rose 0.9% after announcing second quarter earnings per share of $0.86, beating the Zacks Consensus Estimate of $0.80 • Shares of Reynolds American Inc. ( RAI ) jumped 6.3% after declaring second quarter ...
 Zacks.com16 hours ago

Premarket Biotech Digest: Merck Earnings, Gilead Beats Again, NantKwest Surges

Dr De's Opening Thoughts: GLP-1 Agonists GLP-1 agonists are a class of (currently) SC injected drugs that mimic the behavior of native GLP-1 (glucagon-like peptide) receptors and induce insulin secretion. They also reduce glucagon and help with ...
 TeleTrader.com19 hours ago

Merck tops Wall Street 2Q forecasts

Merck & Co's second-quarter profit plunged by two-thirds, hammered by the sale of its consumer business, unfavourable currency exchange rates, lower sales of some key drugs and hefty one-time charges. The world's fifth-biggest drugmaker by revenue ...
 NineMSN Finance1 day ago Merck Tops Street 2Q Forecasts  ABC News1 day ago Big Pharma Update: Merck (MRK) profit slashed in Q2 as Pfizer (PFE) sales soarns  StockHouse USA1 day ago Merck beats 2Q net income and revenue expectations  Canadian Business Magazine1 day ago

Merck Raises Guidance

Merck & Co., Inc. (NYSE: MRK) said it expects 2015 earnings of $3.45 to $3.55 per share on revenue of $38.6 billion to $39.8 billion. The company's previous guidance was earnings of $3.35 to $3.48 per share and the current consensus earnings ...
 Individual.com1 day ago

Merck (MRK) Showing Bearish Technicals With Resistance At $57.84

Merck & Co Inc. ("MRK) presents a trading opportunity that offers a 3.11% return in just 171 days. A covered call on Merck at the $55.00 level expiring on Jan. '16 offers an assigned return rate of ...
 Individual.com1 day ago Merck (MRK) Trading Near $56.98 Support Level  Individual.com2 days ago Merck (MRK) Showing Resistance Near $58.77  PredictWallStreet5 days ago Merck (MRK) Trading Near $59.15 Resistance Level  Individual.com1 week ago

Merck Adds Johns Hopkins Dean, Former Accenture CFO to Board

Merck & Co. added two members to its board, tapping academia and the consulting industry to bolster its corporate oversight. Paul Rothman, dean of the medical faculty and vice president for medicine of Johns Hopkins University, and Pamela Craig, ...
 Bloomberg1 day ago

Merck raises forecast on strong sales of diabetes, cancer drugs

n">Merck & Co Inc ( MRK.N ) reported a better-than-expected quarterly profit and boosted its full-year earnings forecast as demand for its diabetes and cancer drugs increased. The company also said it expects to reap benefits from its $8.4 billion purchase of ...
 Reuters1 day ago Dollar, Consumer-Care Unit Sale Dent Merck Revenue  FOXBusiness.com1 day ago Merck Increases Forecast Following Strong Sales  WKRB News1 day ago Strong dollar weighs on Merck revenue  Sharenet1 day ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less